- call +1-201-465-4211
- email sales@marketquest.biz
- Call +1-201-465-4211
- Email: sales@marketquest.biz
Ketorolac injection is used for the short-term treatment of moderate to severe pain. It is usually used before or after medical procedures or after surgery. Reducing pain helps you recover more comfortably so that you can return to your normal daily activities. This medication is a nonsteroidal anti-inflammatory drug.
According to our latest study, the global Ketorolac Injection market size was valued at USD 967 million in 2022 and is forecast to a readjusted size of USD 1155.4 million by 2029 with a CAGR of 2.6% during review period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
Global key ketorolac injection 核心厂商 Pfizer, Fresenius Kabi, Fosun Pharma (Gland Pharma) etc. The top 2 companies hold a share about 20%. North America is the largest market, with a share about 40%, followed by Asia-Pacific and Europe with the share about 27% and 20%. In terms of product, 30mg/ml ketorolac injection is the largest segment, with a share over 64%. And in terms of application, the largest application is hospital, followed by clinics.
This report is a detailed and comprehensive analysis for global Ketorolac Injection market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Concentration and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2023, are provided.
Key Features:
Global Ketorolac Injection market size and forecasts, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/K Units), 2018-2029
Global Ketorolac Injection market size and forecasts by region and country, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/K Units), 2018-2029
Global Ketorolac Injection market size and forecasts, by Concentration and by Application, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/K Units), 2018-2029
Global Ketorolac Injection market shares of main players, shipments in revenue ($ Million), sales quantity (K Units), and ASP (US$/K Units), 2018-2023
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Ketorolac Injection
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Ketorolac Injection market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Pfizer, Fresenius Kabi, Fosun Pharma (Gland Pharma), Sagent Pharmaceuticals and Hikma, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Market Segmentation
Ketorolac Injection market is split by Concentration and by Application. For the period 2018-2029, the growth among segments provides accurate calculations and forecasts for consumption value by Concentration, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Concentration
15mg/ml
30mg/ml
Market segment by Application
Hospital
Clinics
Others
Major players covered
Pfizer
Fresenius Kabi
Fosun Pharma (Gland Pharma)
Sagent Pharmaceuticals
Hikma
Lunan Pharma
Alvogen
Chengdu Brilliant Pharmaceuticals
Athenex
Sichuan Medcalo
Julphar Bangladesh Ltd.
Yung Shin Pharm
Tianjin Chase Sun Pharmaceutical
ZISKA Pharmaceuticals
Market segment by region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Ketorolac Injection product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Ketorolac Injection, with price, sales, revenue and global market share of Ketorolac Injection from 2018 to 2023.
Chapter 3, the Ketorolac Injection competitive situation, sales quantity, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Ketorolac Injection breakdown data are shown at the regional level, to show the sales quantity, consumption value and growth by regions, from 2018 to 2029.
Chapter 5 and 6, to segment the sales by Concentration and application, with sales market share and growth rate by concentration, application, from 2018 to 2029.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value and market share for key countries in the world, from 2017 to 2022.and Ketorolac Injection market forecast, by regions, concentration and application, with sales and revenue, from 2024 to 2029.
Chapter 12, market dynamics, drivers, restraints, trends, Porters Five Forces analysis, and Influence of COVID-19 and Russia-Ukraine War.
Chapter 13, the key raw materials and key suppliers, and industry chain of Ketorolac Injection.
Chapter 14 and 15, to describe Ketorolac Injection sales channel, distributors, customers, research findings and conclusion.
The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.
Market is segmented on the basis:
The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.
The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.
1 Market Overview
1.1 Product Overview and Scope of Ketorolac Injection
1.2 Market Estimation Caveats and Base Year
1.3 Market Analysis by Concentration
1.3.1 Overview: Global Ketorolac Injection Consumption Value by Concentration: 2018 Versus 2022 Versus 2029
1.3.2 15mg/ml
1.3.3 30mg/ml
1.4 Market Analysis by Application
1.4.1 Overview: Global Ketorolac Injection Consumption Value by Application: 2018 Versus 2022 Versus 2029
1.4.2 Hospital
1.4.3 Clinics
1.4.4 Others
1.5 Global Ketorolac Injection Market Size & Forecast
1.5.1 Global Ketorolac Injection Consumption Value (2018 & 2022 & 2029)
1.5.2 Global Ketorolac Injection Sales Quantity (2018-2029)
1.5.3 Global Ketorolac Injection Average Price (2018-2029)
2 Manufacturers Profiles
2.1 Pfizer
2.1.1 Pfizer Details
2.1.2 Pfizer Major Business
2.1.3 Pfizer Ketorolac Injection Product and Services
2.1.4 Pfizer Ketorolac Injection Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.1.5 Pfizer Recent Developments/Updates
2.2 Fresenius Kabi
2.2.1 Fresenius Kabi Details
2.2.2 Fresenius Kabi Major Business
2.2.3 Fresenius Kabi Ketorolac Injection Product and Services
2.2.4 Fresenius Kabi Ketorolac Injection Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.2.5 Fresenius Kabi Recent Developments/Updates
2.3 Fosun Pharma (Gland Pharma)
2.3.1 Fosun Pharma (Gland Pharma) Details
2.3.2 Fosun Pharma (Gland Pharma) Major Business
2.3.3 Fosun Pharma (Gland Pharma) Ketorolac Injection Product and Services
2.3.4 Fosun Pharma (Gland Pharma) Ketorolac Injection Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.3.5 Fosun Pharma (Gland Pharma) Recent Developments/Updates
2.4 Sagent Pharmaceuticals
2.4.1 Sagent Pharmaceuticals Details
2.4.2 Sagent Pharmaceuticals Major Business
2.4.3 Sagent Pharmaceuticals Ketorolac Injection Product and Services
2.4.4 Sagent Pharmaceuticals Ketorolac Injection Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.4.5 Sagent Pharmaceuticals Recent Developments/Updates
2.5 Hikma
2.5.1 Hikma Details
2.5.2 Hikma Major Business
2.5.3 Hikma Ketorolac Injection Product and Services
2.5.4 Hikma Ketorolac Injection Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.5.5 Hikma Recent Developments/Updates
2.6 Lunan Pharma
2.6.1 Lunan Pharma Details
2.6.2 Lunan Pharma Major Business
2.6.3 Lunan Pharma Ketorolac Injection Product and Services
2.6.4 Lunan Pharma Ketorolac Injection Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.6.5 Lunan Pharma Recent Developments/Updates
2.7 Alvogen
2.7.1 Alvogen Details
2.7.2 Alvogen Major Business
2.7.3 Alvogen Ketorolac Injection Product and Services
2.7.4 Alvogen Ketorolac Injection Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.7.5 Alvogen Recent Developments/Updates
2.8 Chengdu Brilliant Pharmaceuticals
2.8.1 Chengdu Brilliant Pharmaceuticals Details
2.8.2 Chengdu Brilliant Pharmaceuticals Major Business
2.8.3 Chengdu Brilliant Pharmaceuticals Ketorolac Injection Product and Services
2.8.4 Chengdu Brilliant Pharmaceuticals Ketorolac Injection Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.8.5 Chengdu Brilliant Pharmaceuticals Recent Developments/Updates
2.9 Athenex
2.9.1 Athenex Details
2.9.2 Athenex Major Business
2.9.3 Athenex Ketorolac Injection Product and Services
2.9.4 Athenex Ketorolac Injection Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.9.5 Athenex Recent Developments/Updates
2.10 Sichuan Medcalo
2.10.1 Sichuan Medcalo Details
2.10.2 Sichuan Medcalo Major Business
2.10.3 Sichuan Medcalo Ketorolac Injection Product and Services
2.10.4 Sichuan Medcalo Ketorolac Injection Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.10.5 Sichuan Medcalo Recent Developments/Updates
2.11 Julphar Bangladesh Ltd.
2.11.1 Julphar Bangladesh Ltd. Details
2.11.2 Julphar Bangladesh Ltd. Major Business
2.11.3 Julphar Bangladesh Ltd. Ketorolac Injection Product and Services
2.11.4 Julphar Bangladesh Ltd. Ketorolac Injection Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.11.5 Julphar Bangladesh Ltd. Recent Developments/Updates
2.12 Yung Shin Pharm
2.12.1 Yung Shin Pharm Details
2.12.2 Yung Shin Pharm Major Business
2.12.3 Yung Shin Pharm Ketorolac Injection Product and Services
2.12.4 Yung Shin Pharm Ketorolac Injection Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.12.5 Yung Shin Pharm Recent Developments/Updates
2.13 Tianjin Chase Sun Pharmaceutical
2.13.1 Tianjin Chase Sun Pharmaceutical Details
2.13.2 Tianjin Chase Sun Pharmaceutical Major Business
2.13.3 Tianjin Chase Sun Pharmaceutical Ketorolac Injection Product and Services
2.13.4 Tianjin Chase Sun Pharmaceutical Ketorolac Injection Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.13.5 Tianjin Chase Sun Pharmaceutical Recent Developments/Updates
2.14 ZISKA Pharmaceuticals
2.14.1 ZISKA Pharmaceuticals Details
2.14.2 ZISKA Pharmaceuticals Major Business
2.14.3 ZISKA Pharmaceuticals Ketorolac Injection Product and Services
2.14.4 ZISKA Pharmaceuticals Ketorolac Injection Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.14.5 ZISKA Pharmaceuticals Recent Developments/Updates
3 Competitive Environment: Ketorolac Injection by Manufacturer
3.1 Global Ketorolac Injection Sales Quantity by Manufacturer (2018-2023)
3.2 Global Ketorolac Injection Revenue by Manufacturer (2018-2023)
3.3 Global Ketorolac Injection Average Price by Manufacturer (2018-2023)
3.4 Market Share Analysis (2022)
3.4.1 Producer Shipments of Ketorolac Injection by Manufacturer Revenue ($MM) and Market Share (%): 2022
3.4.2 Top 3 Ketorolac Injection Manufacturer Market Share in 2022
3.4.2 Top 6 Ketorolac Injection Manufacturer Market Share in 2022
3.5 Ketorolac Injection Market: Overall Company Footprint Analysis
3.5.1 Ketorolac Injection Market: Region Footprint
3.5.2 Ketorolac Injection Market: Company Product Type Footprint
3.5.3 Ketorolac Injection Market: Company Product Application Footprint
3.6 New Market Entrants and Barriers to Market Entry
3.7 Mergers, Acquisition, Agreements, and Collaborations
4 Consumption Analysis by Region
4.1 Global Ketorolac Injection Market Size by Region
4.1.1 Global Ketorolac Injection Sales Quantity by Region (2018-2029)
4.1.2 Global Ketorolac Injection Consumption Value by Region (2018-2029)
4.1.3 Global Ketorolac Injection Average Price by Region (2018-2029)
4.2 North America Ketorolac Injection Consumption Value (2018-2029)
4.3 Europe Ketorolac Injection Consumption Value (2018-2029)
4.4 Asia-Pacific Ketorolac Injection Consumption Value (2018-2029)
4.5 South America Ketorolac Injection Consumption Value (2018-2029)
4.6 Middle East and Africa Ketorolac Injection Consumption Value (2018-2029)
5 Market Segment by Concentration
5.1 Global Ketorolac Injection Sales Quantity by Concentration (2018-2029)
5.2 Global Ketorolac Injection Consumption Value by Concentration (2018-2029)
5.3 Global Ketorolac Injection Average Price by Concentration (2018-2029)
6 Market Segment by Application
6.1 Global Ketorolac Injection Sales Quantity by Application (2018-2029)
6.2 Global Ketorolac Injection Consumption Value by Application (2018-2029)
6.3 Global Ketorolac Injection Average Price by Application (2018-2029)
7 North America
7.1 North America Ketorolac Injection Sales Quantity by Concentration (2018-2029)
7.2 North America Ketorolac Injection Sales Quantity by Application (2018-2029)
7.3 North America Ketorolac Injection Market Size by Country
7.3.1 North America Ketorolac Injection Sales Quantity by Country (2018-2029)
7.3.2 North America Ketorolac Injection Consumption Value by Country (2018-2029)
7.3.3 United States Market Size and Forecast (2018-2029)
7.3.4 Canada Market Size and Forecast (2018-2029)
7.3.5 Mexico Market Size and Forecast (2018-2029)
8 Europe
8.1 Europe Ketorolac Injection Sales Quantity by Concentration (2018-2029)
8.2 Europe Ketorolac Injection Sales Quantity by Application (2018-2029)
8.3 Europe Ketorolac Injection Market Size by Country
8.3.1 Europe Ketorolac Injection Sales Quantity by Country (2018-2029)
8.3.2 Europe Ketorolac Injection Consumption Value by Country (2018-2029)
8.3.3 Germany Market Size and Forecast (2018-2029)
8.3.4 France Market Size and Forecast (2018-2029)
8.3.5 United Kingdom Market Size and Forecast (2018-2029)
8.3.6 Russia Market Size and Forecast (2018-2029)
8.3.7 Italy Market Size and Forecast (2018-2029)
9 Asia-Pacific
9.1 Asia-Pacific Ketorolac Injection Sales Quantity by Concentration (2018-2029)
9.2 Asia-Pacific Ketorolac Injection Sales Quantity by Application (2018-2029)
9.3 Asia-Pacific Ketorolac Injection Market Size by Region
9.3.1 Asia-Pacific Ketorolac Injection Sales Quantity by Region (2018-2029)
9.3.2 Asia-Pacific Ketorolac Injection Consumption Value by Region (2018-2029)
9.3.3 China Market Size and Forecast (2018-2029)
9.3.4 Japan Market Size and Forecast (2018-2029)
9.3.5 Korea Market Size and Forecast (2018-2029)
9.3.6 India Market Size and Forecast (2018-2029)
9.3.7 Southeast Asia Market Size and Forecast (2018-2029)
9.3.8 Australia Market Size and Forecast (2018-2029)
10 South America
10.1 South America Ketorolac Injection Sales Quantity by Concentration (2018-2029)
10.2 South America Ketorolac Injection Sales Quantity by Application (2018-2029)
10.3 South America Ketorolac Injection Market Size by Country
10.3.1 South America Ketorolac Injection Sales Quantity by Country (2018-2029)
10.3.2 South America Ketorolac Injection Consumption Value by Country (2018-2029)
10.3.3 Brazil Market Size and Forecast (2018-2029)
10.3.4 Argentina Market Size and Forecast (2018-2029)
11 Middle East & Africa
11.1 Middle East & Africa Ketorolac Injection Sales Quantity by Concentration (2018-2029)
11.2 Middle East & Africa Ketorolac Injection Sales Quantity by Application (2018-2029)
11.3 Middle East & Africa Ketorolac Injection Market Size by Country
11.3.1 Middle East & Africa Ketorolac Injection Sales Quantity by Country (2018-2029)
11.3.2 Middle East & Africa Ketorolac Injection Consumption Value by Country (2018-2029)
11.3.3 Turkey Market Size and Forecast (2018-2029)
11.3.4 Egypt Market Size and Forecast (2018-2029)
11.3.5 Saudi Arabia Market Size and Forecast (2018-2029)
11.3.6 South Africa Market Size and Forecast (2018-2029)
12 Market Dynamics
12.1 Ketorolac Injection Market Drivers
12.2 Ketorolac Injection Market Restraints
12.3 Ketorolac Injection Trends Analysis
12.4 Porters Five Forces Analysis
12.4.1 Threat of New Entrants
12.4.2 Bargaining Power of Suppliers
12.4.3 Bargaining Power of Buyers
12.4.4 Threat of Substitutes
12.4.5 Competitive Rivalry
12.5 Influence of COVID-19 and Russia-Ukraine War
12.5.1 Influence of COVID-19
12.5.2 Influence of Russia-Ukraine War
13 Raw Material and Industry Chain
13.1 Raw Material of Ketorolac Injection and Key Manufacturers
13.2 Manufacturing Costs Percentage of Ketorolac Injection
13.3 Ketorolac Injection Production Process
13.4 Ketorolac Injection Industrial Chain
14 Shipments by Distribution Channel
14.1 Sales Channel
14.1.1 Direct to End-User
14.1.2 Distributors
14.2 Ketorolac Injection Typical Distributors
14.3 Ketorolac Injection Typical Customers
15 Research Findings and Conclusion
16 Appendix
16.1 Methodology
16.2 Research Process and Data Source
16.3 Disclaimer
List of Tables
Table 1. Global Ketorolac Injection Consumption Value by Concentration, (USD Million), 2018 & 2022 & 2029
Table 2. Global Ketorolac Injection Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
Table 3. Pfizer Basic Information, Manufacturing Base and Competitors
Table 4. Pfizer Major Business
Table 5. Pfizer Ketorolac Injection Product and Services
Table 6. Pfizer Ketorolac Injection Sales Quantity (K Units), Average Price (US$/K Units), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 7. Pfizer Recent Developments/Updates
Table 8. Fresenius Kabi Basic Information, Manufacturing Base and Competitors
Table 9. Fresenius Kabi Major Business
Table 10. Fresenius Kabi Ketorolac Injection Product and Services
Table 11. Fresenius Kabi Ketorolac Injection Sales Quantity (K Units), Average Price (US$/K Units), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 12. Fresenius Kabi Recent Developments/Updates
Table 13. Fosun Pharma (Gland Pharma) Basic Information, Manufacturing Base and Competitors
Table 14. Fosun Pharma (Gland Pharma) Major Business
Table 15. Fosun Pharma (Gland Pharma) Ketorolac Injection Product and Services
Table 16. Fosun Pharma (Gland Pharma) Ketorolac Injection Sales Quantity (K Units), Average Price (US$/K Units), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 17. Fosun Pharma (Gland Pharma) Recent Developments/Updates
Table 18. Sagent Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 19. Sagent Pharmaceuticals Major Business
Table 20. Sagent Pharmaceuticals Ketorolac Injection Product and Services
Table 21. Sagent Pharmaceuticals Ketorolac Injection Sales Quantity (K Units), Average Price (US$/K Units), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 22. Sagent Pharmaceuticals Recent Developments/Updates
Table 23. Hikma Basic Information, Manufacturing Base and Competitors
Table 24. Hikma Major Business
Table 25. Hikma Ketorolac Injection Product and Services
Table 26. Hikma Ketorolac Injection Sales Quantity (K Units), Average Price (US$/K Units), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 27. Hikma Recent Developments/Updates
Table 28. Lunan Pharma Basic Information, Manufacturing Base and Competitors
Table 29. Lunan Pharma Major Business
Table 30. Lunan Pharma Ketorolac Injection Product and Services
Table 31. Lunan Pharma Ketorolac Injection Sales Quantity (K Units), Average Price (US$/K Units), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 32. Lunan Pharma Recent Developments/Updates
Table 33. Alvogen Basic Information, Manufacturing Base and Competitors
Table 34. Alvogen Major Business
Table 35. Alvogen Ketorolac Injection Product and Services
Table 36. Alvogen Ketorolac Injection Sales Quantity (K Units), Average Price (US$/K Units), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 37. Alvogen Recent Developments/Updates
Table 38. Chengdu Brilliant Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 39. Chengdu Brilliant Pharmaceuticals Major Business
Table 40. Chengdu Brilliant Pharmaceuticals Ketorolac Injection Product and Services
Table 41. Chengdu Brilliant Pharmaceuticals Ketorolac Injection Sales Quantity (K Units), Average Price (US$/K Units), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 42. Chengdu Brilliant Pharmaceuticals Recent Developments/Updates
Table 43. Athenex Basic Information, Manufacturing Base and Competitors
Table 44. Athenex Major Business
Table 45. Athenex Ketorolac Injection Product and Services
Table 46. Athenex Ketorolac Injection Sales Quantity (K Units), Average Price (US$/K Units), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 47. Athenex Recent Developments/Updates
Table 48. Sichuan Medcalo Basic Information, Manufacturing Base and Competitors
Table 49. Sichuan Medcalo Major Business
Table 50. Sichuan Medcalo Ketorolac Injection Product and Services
Table 51. Sichuan Medcalo Ketorolac Injection Sales Quantity (K Units), Average Price (US$/K Units), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 52. Sichuan Medcalo Recent Developments/Updates
Table 53. Julphar Bangladesh Ltd. Basic Information, Manufacturing Base and Competitors
Table 54. Julphar Bangladesh Ltd. Major Business
Table 55. Julphar Bangladesh Ltd. Ketorolac Injection Product and Services
Table 56. Julphar Bangladesh Ltd. Ketorolac Injection Sales Quantity (K Units), Average Price (US$/K Units), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 57. Julphar Bangladesh Ltd. Recent Developments/Updates
Table 58. Yung Shin Pharm Basic Information, Manufacturing Base and Competitors
Table 59. Yung Shin Pharm Major Business
Table 60. Yung Shin Pharm Ketorolac Injection Product and Services
Table 61. Yung Shin Pharm Ketorolac Injection Sales Quantity (K Units), Average Price (US$/K Units), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 62. Yung Shin Pharm Recent Developments/Updates
Table 63. Tianjin Chase Sun Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 64. Tianjin Chase Sun Pharmaceutical Major Business
Table 65. Tianjin Chase Sun Pharmaceutical Ketorolac Injection Product and Services
Table 66. Tianjin Chase Sun Pharmaceutical Ketorolac Injection Sales Quantity (K Units), Average Price (US$/K Units), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 67. Tianjin Chase Sun Pharmaceutical Recent Developments/Updates
Table 68. ZISKA Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 69. ZISKA Pharmaceuticals Major Business
Table 70. ZISKA Pharmaceuticals Ketorolac Injection Product and Services
Table 71. ZISKA Pharmaceuticals Ketorolac Injection Sales Quantity (K Units), Average Price (US$/K Units), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 72. ZISKA Pharmaceuticals Recent Developments/Updates
Table 73. Global Ketorolac Injection Sales Quantity by Manufacturer (2018-2023) & (K Units)
Table 74. Global Ketorolac Injection Revenue by Manufacturer (2018-2023) & (USD Million)
Table 75. Global Ketorolac Injection Average Price by Manufacturer (2018-2023) & (US$/K Units)
Table 76. Market Position of Manufacturers in Ketorolac Injection, (Tier 1, Tier 2, and Tier 3), Based on Consumption Value in 2022
Table 77. Head Office and Ketorolac Injection Production Site of Key Manufacturer
Table 78. Ketorolac Injection Market: Company Product Type Footprint
Table 79. Ketorolac Injection Market: Company Product Application Footprint
Table 80. Ketorolac Injection New Market Entrants and Barriers to Market Entry
Table 81. Ketorolac Injection Mergers, Acquisition, Agreements, and Collaborations
Table 82. Global Ketorolac Injection Sales Quantity by Region (2018-2023) & (K Units)
Table 83. Global Ketorolac Injection Sales Quantity by Region (2024-2029) & (K Units)
Table 84. Global Ketorolac Injection Consumption Value by Region (2018-2023) & (USD Million)
Table 85. Global Ketorolac Injection Consumption Value by Region (2024-2029) & (USD Million)
Table 86. Global Ketorolac Injection Average Price by Region (2018-2023) & (US$/K Units)
Table 87. Global Ketorolac Injection Average Price by Region (2024-2029) & (US$/K Units)
Table 88. Global Ketorolac Injection Sales Quantity by Concentration (2018-2023) & (K Units)
Table 89. Global Ketorolac Injection Sales Quantity by Concentration (2024-2029) & (K Units)
Table 90. Global Ketorolac Injection Consumption Value by Concentration (2018-2023) & (USD Million)
Table 91. Global Ketorolac Injection Consumption Value by Concentration (2024-2029) & (USD Million)
Table 92. Global Ketorolac Injection Average Price by Concentration (2018-2023) & (US$/K Units)
Table 93. Global Ketorolac Injection Average Price by Concentration (2024-2029) & (US$/K Units)
Table 94. Global Ketorolac Injection Sales Quantity by Application (2018-2023) & (K Units)
Table 95. Global Ketorolac Injection Sales Quantity by Application (2024-2029) & (K Units)
Table 96. Global Ketorolac Injection Consumption Value by Application (2018-2023) & (USD Million)
Table 97. Global Ketorolac Injection Consumption Value by Application (2024-2029) & (USD Million)
Table 98. Global Ketorolac Injection Average Price by Application (2018-2023) & (US$/K Units)
Table 99. Global Ketorolac Injection Average Price by Application (2024-2029) & (US$/K Units)
Table 100. North America Ketorolac Injection Sales Quantity by Concentration (2018-2023) & (K Units)
Table 101. North America Ketorolac Injection Sales Quantity by Concentration (2024-2029) & (K Units)
Table 102. North America Ketorolac Injection Sales Quantity by Application (2018-2023) & (K Units)
Table 103. North America Ketorolac Injection Sales Quantity by Application (2024-2029) & (K Units)
Table 104. North America Ketorolac Injection Sales Quantity by Country (2018-2023) & (K Units)
Table 105. North America Ketorolac Injection Sales Quantity by Country (2024-2029) & (K Units)
Table 106. North America Ketorolac Injection Consumption Value by Country (2018-2023) & (USD Million)
Table 107. North America Ketorolac Injection Consumption Value by Country (2024-2029) & (USD Million)
Table 108. Europe Ketorolac Injection Sales Quantity by Concentration (2018-2023) & (K Units)
Table 109. Europe Ketorolac Injection Sales Quantity by Concentration (2024-2029) & (K Units)
Table 110. Europe Ketorolac Injection Sales Quantity by Application (2018-2023) & (K Units)
Table 111. Europe Ketorolac Injection Sales Quantity by Application (2024-2029) & (K Units)
Table 112. Europe Ketorolac Injection Sales Quantity by Country (2018-2023) & (K Units)
Table 113. Europe Ketorolac Injection Sales Quantity by Country (2024-2029) & (K Units)
Table 114. Europe Ketorolac Injection Consumption Value by Country (2018-2023) & (USD Million)
Table 115. Europe Ketorolac Injection Consumption Value by Country (2024-2029) & (USD Million)
Table 116. Asia-Pacific Ketorolac Injection Sales Quantity by Concentration (2018-2023) & (K Units)
Table 117. Asia-Pacific Ketorolac Injection Sales Quantity by Concentration (2024-2029) & (K Units)
Table 118. Asia-Pacific Ketorolac Injection Sales Quantity by Application (2018-2023) & (K Units)
Table 119. Asia-Pacific Ketorolac Injection Sales Quantity by Application (2024-2029) & (K Units)
Table 120. Asia-Pacific Ketorolac Injection Sales Quantity by Region (2018-2023) & (K Units)
Table 121. Asia-Pacific Ketorolac Injection Sales Quantity by Region (2024-2029) & (K Units)
Table 122. Asia-Pacific Ketorolac Injection Consumption Value by Region (2018-2023) & (USD Million)
Table 123. Asia-Pacific Ketorolac Injection Consumption Value by Region (2024-2029) & (USD Million)
Table 124. South America Ketorolac Injection Sales Quantity by Concentration (2018-2023) & (K Units)
Table 125. South America Ketorolac Injection Sales Quantity by Concentration (2024-2029) & (K Units)
Table 126. South America Ketorolac Injection Sales Quantity by Application (2018-2023) & (K Units)
Table 127. South America Ketorolac Injection Sales Quantity by Application (2024-2029) & (K Units)
Table 128. South America Ketorolac Injection Sales Quantity by Country (2018-2023) & (K Units)
Table 129. South America Ketorolac Injection Sales Quantity by Country (2024-2029) & (K Units)
Table 130. South America Ketorolac Injection Consumption Value by Country (2018-2023) & (USD Million)
Table 131. South America Ketorolac Injection Consumption Value by Country (2024-2029) & (USD Million)
Table 132. Middle East & Africa Ketorolac Injection Sales Quantity by Concentration (2018-2023) & (K Units)
Table 133. Middle East & Africa Ketorolac Injection Sales Quantity by Concentration (2024-2029) & (K Units)
Table 134. Middle East & Africa Ketorolac Injection Sales Quantity by Application (2018-2023) & (K Units)
Table 135. Middle East & Africa Ketorolac Injection Sales Quantity by Application (2024-2029) & (K Units)
Table 136. Middle East & Africa Ketorolac Injection Sales Quantity by Region (2018-2023) & (K Units)
Table 137. Middle East & Africa Ketorolac Injection Sales Quantity by Region (2024-2029) & (K Units)
Table 138. Middle East & Africa Ketorolac Injection Consumption Value by Region (2018-2023) & (USD Million)
Table 139. Middle East & Africa Ketorolac Injection Consumption Value by Region (2024-2029) & (USD Million)
Table 140. Ketorolac Injection Raw Material
Table 141. Key Manufacturers of Ketorolac Injection Raw Materials
Table 142. Ketorolac Injection Typical Distributors
Table 143. Ketorolac Injection Typical Customers
List of Figures
Figure 1. Ketorolac Injection Picture
Figure 2. Global Ketorolac Injection Consumption Value by Concentration, (USD Million), 2018 & 2022 & 2029
Figure 3. Global Ketorolac Injection Consumption Value Market Share by Concentration in 2022
Figure 4. 15mg/ml Examples
Figure 5. 30mg/ml Examples
Figure 6. Global Ketorolac Injection Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
Figure 7. Global Ketorolac Injection Consumption Value Market Share by Application in 2022
Figure 8. Hospital Examples
Figure 9. Clinics Examples
Figure 10. Others Examples
Figure 11. Global Ketorolac Injection Consumption Value, (USD Million): 2018 & 2022 & 2029
Figure 12. Global Ketorolac Injection Consumption Value and Forecast (2018-2029) & (USD Million)
Figure 13. Global Ketorolac Injection Sales Quantity (2018-2029) & (K Units)
Figure 14. Global Ketorolac Injection Average Price (2018-2029) & (US$/K Units)
Figure 15. Global Ketorolac Injection Sales Quantity Market Share by Manufacturer in 2022
Figure 16. Global Ketorolac Injection Consumption Value Market Share by Manufacturer in 2022
Figure 17. Producer Shipments of Ketorolac Injection by Manufacturer Sales Quantity ($MM) and Market Share (%): 2021
Figure 18. Top 3 Ketorolac Injection Manufacturer (Consumption Value) Market Share in 2022
Figure 19. Top 6 Ketorolac Injection Manufacturer (Consumption Value) Market Share in 2022
Figure 20. Global Ketorolac Injection Sales Quantity Market Share by Region (2018-2029)
Figure 21. Global Ketorolac Injection Consumption Value Market Share by Region (2018-2029)
Figure 22. North America Ketorolac Injection Consumption Value (2018-2029) & (USD Million)
Figure 23. Europe Ketorolac Injection Consumption Value (2018-2029) & (USD Million)
Figure 24. Asia-Pacific Ketorolac Injection Consumption Value (2018-2029) & (USD Million)
Figure 25. South America Ketorolac Injection Consumption Value (2018-2029) & (USD Million)
Figure 26. Middle East & Africa Ketorolac Injection Consumption Value (2018-2029) & (USD Million)
Figure 27. Global Ketorolac Injection Sales Quantity Market Share by Concentration (2018-2029)
Figure 28. Global Ketorolac Injection Consumption Value Market Share by Concentration (2018-2029)
Figure 29. Global Ketorolac Injection Average Price by Concentration (2018-2029) & (US$/K Units)
Figure 30. Global Ketorolac Injection Sales Quantity Market Share by Application (2018-2029)
Figure 31. Global Ketorolac Injection Consumption Value Market Share by Application (2018-2029)
Figure 32. Global Ketorolac Injection Average Price by Application (2018-2029) & (US$/K Units)
Figure 33. North America Ketorolac Injection Sales Quantity Market Share by Concentration (2018-2029)
Figure 34. North America Ketorolac Injection Sales Quantity Market Share by Application (2018-2029)
Figure 35. North America Ketorolac Injection Sales Quantity Market Share by Country (2018-2029)
Figure 36. North America Ketorolac Injection Consumption Value Market Share by Country (2018-2029)
Figure 37. United States Ketorolac Injection Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 38. Canada Ketorolac Injection Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 39. Mexico Ketorolac Injection Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 40. Europe Ketorolac Injection Sales Quantity Market Share by Concentration (2018-2029)
Figure 41. Europe Ketorolac Injection Sales Quantity Market Share by Application (2018-2029)
Figure 42. Europe Ketorolac Injection Sales Quantity Market Share by Country (2018-2029)
Figure 43. Europe Ketorolac Injection Consumption Value Market Share by Country (2018-2029)
Figure 44. Germany Ketorolac Injection Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 45. France Ketorolac Injection Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 46. United Kingdom Ketorolac Injection Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 47. Russia Ketorolac Injection Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 48. Italy Ketorolac Injection Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 49. Asia-Pacific Ketorolac Injection Sales Quantity Market Share by Concentration (2018-2029)
Figure 50. Asia-Pacific Ketorolac Injection Sales Quantity Market Share by Application (2018-2029)
Figure 51. Asia-Pacific Ketorolac Injection Sales Quantity Market Share by Region (2018-2029)
Figure 52. Asia-Pacific Ketorolac Injection Consumption Value Market Share by Region (2018-2029)
Figure 53. China Ketorolac Injection Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 54. Japan Ketorolac Injection Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 55. Korea Ketorolac Injection Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 56. India Ketorolac Injection Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 57. Southeast Asia Ketorolac Injection Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 58. Australia Ketorolac Injection Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 59. South America Ketorolac Injection Sales Quantity Market Share by Concentration (2018-2029)
Figure 60. South America Ketorolac Injection Sales Quantity Market Share by Application (2018-2029)
Figure 61. South America Ketorolac Injection Sales Quantity Market Share by Country (2018-2029)
Figure 62. South America Ketorolac Injection Consumption Value Market Share by Country (2018-2029)
Figure 63. Brazil Ketorolac Injection Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 64. Argentina Ketorolac Injection Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 65. Middle East & Africa Ketorolac Injection Sales Quantity Market Share by Concentration (2018-2029)
Figure 66. Middle East & Africa Ketorolac Injection Sales Quantity Market Share by Application (2018-2029)
Figure 67. Middle East & Africa Ketorolac Injection Sales Quantity Market Share by Region (2018-2029)
Figure 68. Middle East & Africa Ketorolac Injection Consumption Value Market Share by Region (2018-2029)
Figure 69. Turkey Ketorolac Injection Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 70. Egypt Ketorolac Injection Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 71. Saudi Arabia Ketorolac Injection Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 72. South Africa Ketorolac Injection Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 73. Ketorolac Injection Market Drivers
Figure 74. Ketorolac Injection Market Restraints
Figure 75. Ketorolac Injection Market Trends
Figure 76. Porters Five Forces Analysis
Figure 77. Manufacturing Cost Structure Analysis of Ketorolac Injection in 2022
Figure 78. Manufacturing Process Analysis of Ketorolac Injection
Figure 79. Ketorolac Injection Industrial Chain
Figure 80. Sales Quantity Channel: Direct to End-User vs Distributors
Figure 81. Direct Channel Pros & Cons
Figure 82. Indirect Channel Pros & Cons
Figure 83. Methodology
Figure 84. Research Process and Data Source
Please feel free to write an email to us or to use our electronic ticketing system.
